The United States Food and Drug Administration (FDA) has granted approval for a prefilled syringe of efgartigimod alfa and hyaluronidase-qvfc, enabling adult patients to
Topcon Healthcare has acquired RetInSight GmbH, a privately held company based in Vienna, Austria, renowned for its innovation in retinal imaging artificial intelligenve (AI)
Researchers at Aston University have called for more advice to be given to young people about preventing dry eye disease (DED), after a study1
The National Institutes of Health (NIH) is adopting a new initiative to expand innovative, human-based science while reducing animal use in research. Developing and
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
